Vasc Spec Int.  2024 Dec;40(4):40. 10.5758/vsi.240039.

Management of Renal Angiomyolipomas in Tuberous Sclerosis: A Case Series

Affiliations
  • 1Departments of Vascular Surgery, JSS Academy of Higher Education and Research, Mysuru, India
  • 2Departments of Obstetrics and Gynecology, JSS Academy of Higher Education and Research, Mysuru, India

Abstract

Renal angiomyolipomas, benign tumors composed of blood vessels, adipose tissue, and smooth muscle, affect approximately 70% to 80% of patients with tuberous sclerosis. Angiomyolipomas smaller than 4 cm are usually asymptomatic, whereas larger ones can cause lumbar pain, anemia, and hematuria. Contrary to its sporadic counterparts, tuberous sclerosis-associated angiomyolipomas often present at a young age, are multicentric and large, and carry a higher risk of life-threatening hemorrhage. Therapeutic strategies include selective tumor embolization, nephrectomy for severe cases, and medical treatment such as everolimus. Despite a correlation between tuberous sclerosis and renal angiomyolipomas and their described high complication rates in literature, disease awareness in clinical practice remains low. This case series describes the management and outcomes of three patients with tuberous sclerosis-associated renal angiomyolipomas treated with selective arterial embolization.

Keyword

Tuberous sclerosis; Renal angiomyolipoma; Embolization
Full Text Links
  • VSI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr